Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001726495-19-000001
Filing Date
2019-09-25
Accepted
2019-09-25 16:32:10
Documents
1
Effectiveness Date
2019-09-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8259
  Complete submission text file 0001726495-19-000001.txt   9293
Mailing Address 1240 HAYES STREET, #7 SAN FRANCISCO CA 94117
Business Address 1240 HAYES STREET, #7 SAN FRANCISCO CA 94117 415-634-5170
Spotlight Therapeutics, Inc. (Filer) CIK: 0001726495 (see all company filings)

EIN.: 821864449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-349629 | Film No.: 191114560